HNB
NTLA icon

Huntington National Bank’s Intellia Therapeutics NTLA Stock Holding History

Huntington National Bank’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.58K Hold
357
– – ﹤0.01% 2087
2025
Q4 		$3.21K Buy
357
+237
+198% +$3.26K ﹤0.01% 2096
2025
Q3 		$2.07K Buy
120
+63
+111% +$776 ﹤0.01% 2193
2025
Q2 		$535 Buy
+57
New +$468 ﹤0.01% 2426
2024
Q4 		– Sell
-70
Closed -$1.44K – 4243
2024
Q3 		$1.44K Hold
70
– – ﹤0.01% 2316
2024
Q2 		$1.57K Sell
70
-74
-51% -$1.76K ﹤0.01% 2229
2024
Q1 		$3.96K Buy
144
+80
+125% +$2.22K ﹤0.01% 1970
2023
Q4 		$1.95K Buy
+64
New +$1.84K ﹤0.01% 2081

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return